DOI QR코드

DOI QR Code

Isolation of Peripheral Blood-Derived Mesenchymal Stem Cells in Mares and Foals

  • Ye-Eun Oh (College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University) ;
  • Eun-Bee Lee (College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University) ;
  • Jong-Pil Seo (College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University)
  • Received : 2023.06.30
  • Accepted : 2023.09.18
  • Published : 2023.10.31

Abstract

Peripheral blood-derived mesenchymal stem cells (PB-MSCs) have shown promise in cell-based therapy, as they can be harvested with ease through minimally invasive procedures. This study aimed to isolate PB-MSCs from foals and mares and to compare the proliferation and cellular characteristics of the PB-MSCs between the two groups. Six pairs of mares and their foals were used in this study. MSCs were isolated from PB by direct plating in a tissue culture medium, and cell proliferation (population doubling time [PDT], and colony-forming unit-fibroblast assay [CFU-F]), and characterization (morphology, plastic adhesiveness, colony formation, trilineage differentiation) were examined. There was no significant difference in the PB-MSC yield, CFU-F, and PDT between the mares and foals. PB-MSCs from both mares and foals showed typical MSC characteristics in terms of spindle-shaped morphology, plastic adhesive properties, formation of colonies, trilineage differentiation. These results suggest that PB-MSCs isolated from horses, both adult horses, and foals, can be used for equine cell-based therapy.

Keywords

Acknowledgement

This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Republic of Korea (grant number NRF-2017R1C1B1006030).

References

  1. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol 2006; 7: 14. 
  2. Campanati A, Orciani M, Consales V, Lazzarini R, Ganzetti G, Di Benedetto G, et al. Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1-Th17/Th2 imbalance of psoriasis. Arch Dermatol Res 2014; 306: 915-920.  https://doi.org/10.1007/s00403-014-1493-3
  3. Dhar M, Neilsen N, Beatty K, Eaker S, Adair H, Geiser D. Equine peripheral blood-derived mesenchymal stem cells: isolation, identification, trilineage differentiation and effect of hyperbaric oxygen treatment. Equine Vet J 2012; 44: 600-605.  https://doi.org/10.1111/j.2042-3306.2011.00536.x
  4. Fu WL, Zhou CY, Yu JK. A new source of mesenchymal stem cells for articular cartilage repair: MSCs derived from mobilized peripheral blood share similar biological characteristics in vitro and chondrogenesis in vivo as MSCs from bone marrow in a rabbit model. Am J Sports Med 2014; 42: 592-601.  https://doi.org/10.1177/0363546513512778
  5. Giovannini S, Brehm W, Mainil-Varlet P, Nesic D. Multilineage differentiation potential of equine blood-derived fibroblast-like cells. Differentiation 2008; 76: 118-129.  https://doi.org/10.1111/j.1432-0436.2007.00207.x
  6. Ishikawa S, Horinouchi C, Mizoguchi R, Senokuchi A, Kamikakimoto R, Murata D, et al. Isolation of equine peripheral blood stem cells from a Japanese native horse. J Equine Sci 2017; 28: 153-158.  https://doi.org/10.1294/jes.28.153
  7. Koerner J, Nesic D, Romero JD, Brehm W, Mainil-Varlet P, Grogan SP. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells. Stem Cells 2006; 24: 1613-1619.  https://doi.org/10.1634/stemcells.2005-0264
  8. Longhini ALF, Salazar TE, Vieira C, Trinh T, Duan Y, Pay LM, et al. Peripheral blood-derived mesenchymal stem cells demonstrate immunomodulatory potential for therapeutic use in horses. PLoS One 2019; 14: e0212642. 
  9. Seo JP, Tsuzuki N, Haneda S, Yamada K, Furuoka H, Tabata Y, et al. Comparison of allogeneic platelet lysate and fetal bovine serum for in vitro expansion of equine bone marrow-derived mesenchymal stem cells. Res Vet Sci 2013; 95: 693-698.  https://doi.org/10.1016/j.rvsc.2013.04.024
  10. Seo JP, Tsuzuki N, Haneda S, Yamada K, Furuoka H, Tabata Y, et al. Proliferation of equine bone marrow-derived mesenchymal stem cells in gelatin/β-tricalcium phosphate sponges. Res Vet Sci 2012; 93: 1481-1486.  https://doi.org/10.1016/j.rvsc.2012.02.013
  11. Spaas JH, De Schauwer C, Cornillie P, Meyer E, Van Soom A, Van de Walle GR. Culture and characterisation of equine peripheral blood mesenchymal stromal cells. Vet J 2013; 195: 107-113.  https://doi.org/10.1016/j.tvjl.2012.05.006
  12. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003; 33: 919-926.  https://doi.org/10.1016/j.bone.2003.07.005
  13. Stewart MC. Cell-based therapies: current issues and future directions. Vet Clin North Am Equine Pract 2011; 27: 393-399.  https://doi.org/10.1016/j.cveq.2011.07.001
  14. Vidal MA, Kilroy GE, Johnson JR, Lopez MJ, Moore RM, Gimble JM. Cell growth characteristics and differentiation frequency of adherent equine bone marrow-derived mesenchymal stromal cells: adipogenic and osteogenic capacity. Vet Surg 2006; 35: 601-610. https://doi.org/10.1111/j.1532-950X.2006.00197.x